Cargando…
The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
PURPOSE: Biomarkers with minimally invasive and reproducible objective metrics provide the key to future paradigm shifts in understanding of the underlying causes of dry eye disease (DED) and approaches to treatment of DED. We review biomarkers and their validity in providing objective metrics for D...
Autores principales: | Roy, Neeta S., Wei, Yi, Kuklinski, Eric, Asbell, Penny A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455411/ https://www.ncbi.nlm.nih.gov/pubmed/28475698 http://dx.doi.org/10.1167/iovs.17-21709 |
Ejemplares similares
-
Assessing the Quality, Reliability, and Readability of Online Information on Dry Eye Disease
por: Oydanich, Marko, et al.
Publicado: (2022) -
Association of Ocular Surface Immune Cells With Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study
por: Kuklinski, Eric J., et al.
Publicado: (2023) -
Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017) -
Defining the needs and preferences of patients with dry eye disease
por: Asbell, Penny, et al.
Publicado: (2019) -
Comparing the needs and preferences of patients with moderate and severe dry eye symptoms across four countries
por: Messmer, Elisabeth, et al.
Publicado: (2019)